120 related articles for article (PubMed ID: 4129869)
1. Inhibition of drug metabolism in man.
Vesell ES; Passananti GT
Drug Metab Dispos; 1973; 1(1):402-10. PubMed ID: 4129869
[No Abstract] [Full Text] [Related]
2. Impairment of drug metabolism in man by allopurinol and nortriptyline.
Vesell ES; Passananti GT; Greene FE
N Engl J Med; 1970 Dec; 283(27):1484-8. PubMed ID: 4098480
[No Abstract] [Full Text] [Related]
3. Genetic and environmental factors affecting drug response in man.
Vesell ES
Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
[No Abstract] [Full Text] [Related]
4. Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.
Vesell ES; Passananti GT; Greene FE; Page JG
Ann N Y Acad Sci; 1971 Jul; 179():752-73. PubMed ID: 4105797
[No Abstract] [Full Text] [Related]
5. Utility of clinical chemical determinations of drug concentrations in biological fluids.
Vessell ES; Passananti GT
Clin Chem; 1971 Sep; 17(9):851-66. PubMed ID: 4105897
[No Abstract] [Full Text] [Related]
6. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
7. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
Albanus L; Jönsson M; Sparf B
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
[TBL] [Abstract][Full Text] [Related]
8. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
Szabó I; Renczes G; Gachályi B
Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
[TBL] [Abstract][Full Text] [Related]
9. Effects of tricyclic antidepressants on drug metabolism.
Pond SM; Graham GG; Birkett DJ; Wade DN
Clin Pharmacol Ther; 1975 Aug; 18(2):191-9. PubMed ID: 50160
[TBL] [Abstract][Full Text] [Related]
10. Interindividual differences in drug oxidation: clinical importance.
Sjöqvist F; von Bahr C
Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
[No Abstract] [Full Text] [Related]
11. IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man.
Burns JJ
Ann N Y Acad Sci; 1968 Jul; 151(2):959-67. PubMed ID: 4189972
[No Abstract] [Full Text] [Related]
12. Drug pharmacokinetics in thyroid dysfunction.
Rodighiero V
Minerva Endocrinol; 1985; 10(2):97-113. PubMed ID: 2415808
[No Abstract] [Full Text] [Related]
13. Linearity and superposition in pharmacokinetics.
Thron CD
Pharmacol Rev; 1974 Mar; 26(1):3-31. PubMed ID: 4133328
[No Abstract] [Full Text] [Related]
14. Anomalous results of studies on drug interaction in man. I. Nortriptyline and antipyrine.
Vesell ES; Passananti GT; Aurori KC
Pharmacology; 1975; 13(2):101-11. PubMed ID: 49899
[TBL] [Abstract][Full Text] [Related]
15. Genetic control of dicumarol levels in man.
Vesell ES; Page JG
J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic drug interactions.
Nies AS; Shand DG; Branch RA
Cardiovasc Clin; 1974; 6(2):43-53. PubMed ID: 4613462
[No Abstract] [Full Text] [Related]
17. [Influence of thyroid function on human drug metabolism].
Gugler R; Eichelbaum M; Schneider-Deters C; Bodem G; Dengler HJ
Verh Dtsch Ges Inn Med; 1973; 79():1230-3. PubMed ID: 4790145
[No Abstract] [Full Text] [Related]
18. [Drug metabolism in liver diseases].
Paumgartner G
Z Gastroenterol Verh; 1979; 16():42-7. PubMed ID: 95370
[No Abstract] [Full Text] [Related]
19. Antipyrine half-life in hyperthyroidism.
Obel AO; Ng'ang'a J; Gitau W
East Afr Med J; 1981 Apr; 58(4):258-62. PubMed ID: 7261979
[No Abstract] [Full Text] [Related]
20. Interindividual differences in rates of drug oxidation in man.
Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
